ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 747461 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 747461; 2) Community: the network communities that were significantly associated with the response to NSC 747461; 3) Molecule: the relationships between components within communities and NSC 747461; 4) MDR: the compounds that were significantly associated with the NSC 747461.

NSC Compound Enrichment Correlation
NSC 30722 Pyrimidine, 2,4,6-trichloro-5-methyl- 0.0385613993886001 -0.058988481
NSC 363787 Kaur-16-en-15-one,1,3,7,11-tetrakis(acetyloxy)-12-hydroxy-, (1.alpha.,3.beta.,7.beta.,11.beta.,12.alpha.)- 0.0385613993886001 0.042426405
NSC 371777 Null 0.0385613993886001 -0.28454068
NSC 372155 2-Propenamide, N-[(cyanoamino)iminomethyl]-2-methyl- 0.0385613993886001 0.010640004
NSC 40618 Cyclohexanone, 2,6-dibenzylidene- (8CI) 0.0385613993886001 -0.055305212
NSC 602617 Benzo[g]quinoxaline-5,10-dione, 5,10-dihydro-2,3-dimethyl- 0.0385613993886001 -0.13842523
NSC 639514 Cyclopentanone, 2-[(dimethylamino)methyl]-5- [[4-[(propionyloxy)methoxy]phenyl]methylene]-, hydrochloride 0.0385613993886001 -0.028409703
NSC 643836 Null 0.0385613993886001 0.24009952
NSC 643846 Null 0.0385613993886001 0.20073135
NSC 647763 Jasplakinolide epoxide C 0.0385613993886001 -0.022476182
Total:65  Current:41    [First] [Prev] [Next] [Last]